News

In The BMJ, Mohga Kamal-Yanni, a consultant in global health policy and access to medicines, argues that the pandemic offers a chance for governments to retain control by sharing knowledge and waiving intellectual property rules.

Researchers find that a microRNA that targets pro-tumor factors increases the sensitivity of oral squamous cell carcinoma to cisplatin.

Researchers have discovered a potential way to disrupt the repair mechanism that cancer cells use after treatment, hindering their ability to regenerate.

According to a preliminary study, children and teens with Tourette syndrome who are treated with an experimental drug called ecopipam may have improved scores on tests of tic severity three months later.

A new platform has been designed to deliver a universal influenza vaccine candidate to immune cells and the results in mice are suggesting that the immunization effectively protects against multiple flu strains.

University of Liverpool scientists have taken a significant step towards unlocking the medical potential of a new class of potent antibiotic capable of killing "superbugs" including MRSA without detectable resistance.

Reducing the levels of a specific microRNA in islet cells can increase insulin secretion, providing a new drug target for type 2 diabetes.

In a pre-clinical study published in Nature Biomedical Engineering, a team at the University of Pennsylvania abbreviated the manufacture of CAR T cells and generated functional cells with enhanced anti-tumor potency in just 24 hours.

The treatment of ADHD is surrounded by degrees of controversy, but a review of animal studies has indicated that prescribing caffeine could help increase attention and retention capacity in adults with ADHD.

New research suggests that the drug sargramostim, currently being trialed in Alzheimer’s patients, may also improve cognitive function in people with Down syndrome.